Trial intelligence / Profile preview

High-dose atorvastatin in post-coarctectomy patients

NL-OMON22766Recruiting

Sponsor
Netherlands Heart Institute
Start
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of atorvastatin in atherosclerosis (2 arms), sponsored by Netherlands Heart Institute. Primary endpoint: Change in carotid intima-media thickness. Started Sep 2007; status: recruiting.

02

Drugs

atorvastatin
03

Conditions

atherosclerosis

Beyond the preview

Go deeper on NL-OMON22766.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22766.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call